Moreover, the onset of AGS was reported in a patient with biallelic mutations in RNASEH2B, despite the use of ruxolitinib for 10 mo while the patient was presymptomatic (Neven et al., 2020). The gene discussed is RNASEH2B; the disease is Aicardi-Goutieres syndrome.